Here are upcoming events in the near future:  

• United Spinal Association/National Spinal Cord Injury Association Webinar: Rehab Solutions: FES Technology and Paralysis, March 13 at 3pm ET.   Click the link above to register for this FREE webinar.  
•  University of Kentucky: Spinal Cord and Brain Injury Research Center,  Lexington, KY, March 22, 2012
• Clarkson University Physical Therapy Student Conclave,  Webinar, March 24, 2012
•  American Spinal Injury Association Annual Meeting,  Colorado Convention Center, Denver, CO, April 18-21, 2012      

Did you miss us at the Abilities Expo in Atlanta?  Click here to view the Neurotech Network page for this workshop.

If you have any suggested events, please let us know at our Conference Inquiry Page on our website.  

Neurotech Network offers free  Informational Fact Sheets to help further understand neurotechnology in non-technical terms.  This is a free resource available in the Educate section of our website. Each Fact Sheet relates to a specific condition or related application.

Recently the Urinary Control Resources Fact Sheet page has been updated to provide better links to resources and information about clinical trials.  This resource is FREE and can be found at this link: Urinary Control Resources  

For the LinkedIn users, there is a new discussion group. The Neuromodulation Network is a group within LinkedIn that covers recent industry news and discussions. Managed by Kim Peterson, RN, it is a great way to connect with those in the industry.   

• Neurotech North America adds TENS Capability to the Kneehab(R) XP Quadriceps Therapy System for Muscle Rehabilitation and Pain Management. Read more of the story here. 
• The MOTOmed Letto2 is being used for movement therapy at the bed side in the hospital setting. Passive movement combined with motor-assisted training up to active resistive exercise covers a wide range of physical conditions. See a video about how this is being used during dialysis. 
• The vagus nerve stimulation system offered by Cyberonics is a treatment for seizure management. Re-designed for new battery capacity, their  AspireHC generator received FDA approval. Read more about this device.  
• Cochlear America announced the arrival of a new rehabilitation app that has been created as a tool for improving listening and spoken language skills of children with hearing loss. The Cochlear HOPE Words App is a part of the  program developed for cochlear implant and hearing aid users to help them achieve their personal best.   
• Neuros Medical received an Investigational Device Exemption approval from the U.S. Food & Drug Administration, allowing it to commence a clinical trial to evaluate the high frequency Electrical Nerve Block technology for use in acute treatment of pain in the residual limb of amputees.
•  Stanford University researchers are enrolling participants in the BrainGate2 study; investigating the feasibility of people with paralysis using a technology that interfaces directly with the brain to control computer cursors, robotic arms, and other assistive devices. Those who may be eligible to enroll in the trial include people with weakness of all four limbs resulting from cervical spinal cord injury, brainstem stroke, muscular dystrophy, or ALS.  
• Swimming with a cochlear implant is now possible. The  new Neptune device offered by Advanced Bionics now has a waterproof processor giving users the capability to hear which in the water.  Learn more by clicking here. 
• The Institute for Functional Recovery (IFR) is a non-profit center of innovation. It is dedicated to transferring technology out of the laboratory and making them available to people for whom they are indented. Learn more about this new center by visiting their website: http://casemed.case.edu/IFR 
• Myomo, Inc.,  offers technology that combines robotics and neuroscience to help individuals with neurological conditions such as stroke, brain injuries, spinal cord injuries, multiple sclerosis, and ALS to re-engage weak muscles and restore movement.  Learn more here.  
• Deep Brain Stimulation for Parkinson's Disease has been approved by the FDA for several years.  However, a recent study was published in the online version of the journal The Lancet Neurology, featuring results of using constant current. In the study, participants with advanced Parkinson's disease who received constant current deep brain stimulation experience improved motor symptoms and quality of life. Read the full news release by clicking here.  
• Researchers from the National Institutes of Health presented a study that shows the WalkAide System successfully improves mobility by significantly increasing ankle control during walking in children with foot drop due to Cerebral Palsy. This is the first study presenting the group results of a commercially-available foot drop stimulator in children with CP.